Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesWomens ImagingRANZCR case series reveals CT's role in identifying ovarian torsionTo ensure timely diagnosis and treatment of ovarian torsion, clinicians must recognize its signs on CT imaging.Womens ImagingMusic lowers anxiety, pain for women undergoing mammographyMRIResearch team casts new light on Cryptococcus infectionWomens ImagingChristiane Kuhl gives insights to Der SpiegelArtificial IntelligenceMerger of radiology and pathology: What’s the next step?